» Articles » PMID: 35096634

Vaginal Dysbiotic Microbiome in Women With No Symptoms of Genital Infections

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

The vaginal microbiome plays a critical role in determining the progression of female genital tract infections; however, little is known about the vaginal microbiota of Indian women. We aimed to investigate the vaginal microbial architecture of women with asymptomatic bacterial vaginosis (BV) (n=20) and normal microbiota (n=19). Microbial diversity was analyzed in vaginal swabs from regularly menstruating women (18-45yrs) by 16S rRNA V3-V4 amplicon (MiSeq Illumina) sequencing. Rarefaction analysis showed a higher number of species in normal flora compared to BV. Alpha diversity as measured by Pielou's evenness revealed microbial diversity was significantly greater in BV samples than normal microbiota (p= 0.0165). Beta diversity comparison using UniFrac metrics indicated distinct microbial communities clustering between normal and BV flora. Firmicutes were the major phyla observed in vaginal specimens of normal microbiota whereas were significantly abundant in BV samples. Notably, the relative abundance of was significantly high in normal microbiota. Conversely , , , , , significantly dominated dysbiotic microbiota. Relative frequency of Lactobacillus decreased significantly in BV (6%) as compared to normal microbiota (35.2%). , more exclusively present in normal microbiota. was detected from both the groups with a relative frequency of 50.4% and 17.2% in normal and BV microbiota respectively. Lefse analysis indicated in the vaginal microbiota as a biomarker for dysbiosis and as a biomarker of a healthy microbiota were negatively correlated to , and . Proteobacteria positively correlated to s, and were shown to be positively correlated to Predicted functional analysis indicated differences in the functional profiles between BV and normal microbiota. Normal microbiota utilized pathways essential for phosphatidylglycerol biosynthesis I & II, peptidoglycan biosynthesis, geranylgeranyl diphosphate biosynthesis I, mevalonate pathway, CoA biosynthesis pathway I and pyrimidine nucleotide salvage; whereas BV bacteria had characteristic aromatic amino acid biosynthesis, pentose phosphate pathway, carbohydrate degradation. In conclusion, women with asymptomatic BV have vaginal microbiota significantly different than women with normal microbiota. Furthermore, the study provides insights into the vaginal microbial structure of Indian women that will enable us to explore the prospective candidates for restoring the vaginal microbiota.

Citing Articles

Berberine alleviates enterotoxigenic -induced intestinal mucosal barrier function damage in a piglet model by modulation of the intestinal microbiome.

Du M, Liu X, Ji X, Wang Y, Liu X, Zhao C Front Nutr. 2025; 11:1494348.

PMID: 39877539 PMC: 11772193. DOI: 10.3389/fnut.2024.1494348.


Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial.

Gill B, Wessels J, Hayes C, Ratcliffe J, Wokuri J, Ball E PLoS One. 2025; 20(1):e0315576.

PMID: 39836666 PMC: 11750099. DOI: 10.1371/journal.pone.0315576.


Cervicovaginal and gastrointestinal microbiomes in gynecological cancers and their roles in therapeutic intervention.

Alhamlan F, Albadawi I, Al-Qahtani A, Awartani K, Obeid D, Tulbah A Front Microbiol. 2024; 15:1489942.

PMID: 39664050 PMC: 11631898. DOI: 10.3389/fmicb.2024.1489942.


The microbiome biomarkers of pregnant women's vaginal area predict preterm prelabor rupture in Western China.

Tang Y, Wang X, Huang J, Jiang Y, Yu F Front Cell Infect Microbiol. 2024; 14:1471027.

PMID: 39544282 PMC: 11560878. DOI: 10.3389/fcimb.2024.1471027.


Berberine alleviates ETEC-induced intestinal inflammation and oxidative stress damage by optimizing intestinal microbial composition in a weaned piglet model.

Wang Y, Zhang Z, Du M, Ji X, Liu X, Zhao C Front Immunol. 2024; 15:1460127.

PMID: 39351242 PMC: 11440249. DOI: 10.3389/fimmu.2024.1460127.


References
1.
Haahr T, Jensen J, Thomsen L, Duus L, Rygaard K, Humaidan P . Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients. Hum Reprod. 2016; 31(4):795-803. DOI: 10.1093/humrep/dew026. View

2.
Douglas G, Maffei V, Zaneveld J, Yurgel S, Brown J, Taylor C . PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020; 38(6):685-688. PMC: 7365738. DOI: 10.1038/s41587-020-0548-6. View

3.
Koumans E, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M . The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007; 34(11):864-9. DOI: 10.1097/OLQ.0b013e318074e565. View

4.
Ravel J, Gajer P, Abdo Z, Schneider G, Koenig S, McCulle S . Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2010; 108 Suppl 1:4680-7. PMC: 3063603. DOI: 10.1073/pnas.1002611107. View

5.
Alisoltani A, Manhanzva M, Potgieter M, Balle C, Bell L, Ross E . Microbial function and genital inflammation in young South African women at high risk of HIV infection. Microbiome. 2020; 8(1):165. PMC: 7679981. DOI: 10.1186/s40168-020-00932-8. View